Innovative Technologies Impacted by COVID–19 Act

Bill: 117-hr-9559
Sponsor: full_name: Rep. Schneider, Bradley Scott [D-IL-10]
Introduced: 2022-12-14
Policy area: Health
Latest action: action_date: 2022-12-14
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summaries:
action_date: 2022-12-14
action_desc: Introduced in House
text: <p><b>Innovative Technologies Impacted by COVID-19 Act</b></p> <p>This bill extends for one year certain Medicare pass-through payment adjustments for new drugs or biologics that would otherwise expire on December 31, 2022.</p>

tv_txt: I 117th CONGRESS 2d Session H. R. 9559 IN THE HOUSE OF REPRESENTATIVES December 14, 2022 Mr. Schneider (for himself, Mr. LaHood , Mr. Perlmutter , Mr. Dunn , and Ms. DeGette ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend title XVIII of the Social Security Act to extend the pass-through period for certain devices.

1. Short title This Act may be cited as the Innovative Technologies Impacted by COVID–19 Act . 2. Extending pass-through status under the Medicare program for certain devices Section 1833(t)(6) of the Social Security Act ( 42 U.S.C. 1395l(t)(6) ) is amended by adding at the end the following new subparagraph: (K) Pass-through extension for certain devices In the case of a device with respect to which the pass-through status under this paragraph would, but for application of this subparagraph, end on December 31, 2022, such pass-through status shall be extended for the 1-year period beginning on January 1, 2023. .